DEL SIGNORE E[au] - Search Results

Year	Number of Results
2003	1
2010	1
2011	3
2012	4
2013	1
2014	2
2016	3
2017	2
2019	2
2020	7
2021	2
2022	2
2023	4
2024	2

1

Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review.

Attili I, Passaro A, Corvaja C, Trillo Aliaga P, Del Signore E, Spitaleri G, de Marinis F. Attili I, et al. Among authors: del signore e. Cancer Treat Rev. 2023 Sep;119:102602. doi: 10.1016/j.ctrv.2023.102602. Epub 2023 Jul 19. Cancer Treat Rev. 2023. PMID: 37481836 Review.

2

Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?

Spitaleri G, Trillo Aliaga P, Attili I, Del Signore E, Corvaja C, Corti C, Crimini E, Passaro A, de Marinis F. Spitaleri G, et al. Among authors: del signore e. Curr Oncol. 2023 May 16;30(5):5072-5092. doi: 10.3390/curroncol30050384. Curr Oncol. 2023. PMID: 37232842 Free PMC article. Review.

3

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target.

Spitaleri G, Trillo Aliaga P, Attili I, Del Signore E, Corvaja C, Corti C, Uliano J, Passaro A, de Marinis F. Spitaleri G, et al. Among authors: del signore e. Cancers (Basel). 2023 Sep 28;15(19):4779. doi: 10.3390/cancers15194779. Cancers (Basel). 2023. PMID: 37835473 Free PMC article. Review.

4

Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach.

Ceresoli GL, Rossi G, Agustoni F, Bonomi L, Borghetti P, Bulotta A, Casartelli C, Cerea G, Colonese F, Del Signore E, Finocchiaro G, Gianoncelli L, Grisanti S, Maiolani M, Pagni F, Proto C, Rijavec E, Vittimberga I, Arcangeli S, Filippi AR. Ceresoli GL, et al. Among authors: del signore e. Crit Rev Oncol Hematol. 2024 Jan 31:104247. doi: 10.1016/j.critrevonc.2023.104247. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 38307393 Review.

5

Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients.

Passaro A, Prelaj A, Pochesci A, Spitaleri G, Rossi G, Del Signore E, Catania C, de Marinis F. Passaro A, et al. Among authors: del signore e. Drugs Today (Barc). 2017 Aug;53(8):435-446. doi: 10.1358/dot.2017.53.8.2676119. Drugs Today (Barc). 2017. PMID: 29119148 Review.

6

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations.

Attili I, Corvaja C, Spitaleri G, Del Signore E, Trillo Aliaga P, Passaro A, de Marinis F. Attili I, et al. Among authors: del signore e. Cancers (Basel). 2023 Oct 20;15(20):5079. doi: 10.3390/cancers15205079. Cancers (Basel). 2023. PMID: 37894445 Free PMC article. Review.

7

The role of multimodal treatment in patients with advanced lung neuroendocrine tumors.

Fazio N, Ungaro A, Spada F, Cella CA, Pisa E, Barberis M, Grana C, Zerini D, Bertani E, Ribero D, Funicelli L, Bonomo G, Ravizza D, Guarize J, De Marinis F, Petrella F, Del Signore E, Pelosi G, Spaggiari L. Fazio N, et al. Among authors: del signore e. J Thorac Dis. 2017 Nov;9(Suppl 15):S1501-S1510. doi: 10.21037/jtd.2017.06.14. J Thorac Dis. 2017. PMID: 29201453 Free PMC article. Review.

8

The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.

Catania C, Muthusamy B, Spitaleri G, Del Signore E, Pennell NA. Catania C, et al. Among authors: del signore e. Clin Lung Cancer. 2022 Mar;23(2):108-115. doi: 10.1016/j.cllc.2021.11.003. Epub 2021 Nov 11. Clin Lung Cancer. 2022. PMID: 34952792 Review.

9

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data.

Passaro A, Attili I, Morganti S, Del Signore E, Gianoncelli L, Spitaleri G, Stati V, Catania C, Curigliano G, de Marinis F. Passaro A, et al. Among authors: del signore e. Cancer Treat Rev. 2020 Sep;89:102085. doi: 10.1016/j.ctrv.2020.102085. Epub 2020 Jul 22. Cancer Treat Rev. 2020. PMID: 32771858 Review.

10

Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.

D'Antonio C, Passaro A, Gori B, Del Signore E, Migliorino MR, Ricciardi S, Fulvi A, de Marinis F. D'Antonio C, et al. Among authors: del signore e. Ther Adv Med Oncol. 2014 May;6(3):101-14. doi: 10.1177/1758834014521110. Ther Adv Med Oncol. 2014. PMID: 24790650 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year